Submitted:
10 June 2025
Posted:
10 June 2025
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Results
2.1. Patient Characteristics and Their Association with Guideline Compliance
2.2. Predictors of the Level of Appropriateness Based on Treatment Guideline Compliance
3. Discussion
4. Materials and Methods
4.1. Study Design
4.2. Study Site and Population
4.3. Inclusion and Exclusion Criteria
4.4. Sample Size and Sampling Technique
4.5. Data Collection
4.6. Antibiotic Appropriateness
4.6. Data Analysis
4.7. Ethical Consideration
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Murray, C.J.; Ikuta, K.S.; Sharara, F.; Swetschinski, L.; Aguilar, G.R.; Gray, A.; Han, C.; Bisignano, C.; Rao, P.; Wool, E.; et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. Lancet 2022, 399, 629–655. [CrossRef]
- Salam, M.A.; Al-Amin, M.Y.; Salam, M.T.; Pawar, J.S.; Akhter, N.; Rabaan, A.A.; Alqumber, M.A.A. Antimicrobial Resistance: A Growing Serious Threat for Global Public Health. Healthcare 2023, 11, 1946. [CrossRef]
- Cassini, A.; Hogberg, L.D.; Plachouras, D.; Quattrocchi, A.; Hoxha, A.; Simonsen, G.S.; Colomb-Cotinat, M.; Kretzschmar, M.E.; Devleesschauwer, B.; Cecchini, M.; et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: A population-level modelling analysis. Lancet Infect. Dis. 2019, 19, 56–66. [CrossRef]
- Bell BG, Schellevis F, Stobberingh E, Goossens H, Pringle M. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14:13. [CrossRef]
- Gautam A. Antimicrobial Resistance: The Next Probable Pandemic. JNMA. 2022, 60, 225–228. [CrossRef]
- Sartorius, B.; Gray, A.P.; Weaver, N.D.; Aguilar, G.R.; Swetschinski, L.R.; Ikuta, K.S.; Mestrovic, T.; Chung, E.; Wool, E.E.; Han, C, et al. The burden of bacterial antimicrobial resistance in the WHO African region in 2019: a cross-country systematic analysis. The Lancet Global Health 2024, 12, e201-e216. [CrossRef]
- Lewnard, J.A.; Charani, E.; Gleason, A.; Hsu, L.Y.; Khan, W.A.; Karkey, A.; Chandler, C.I.R.; Mashe, T.; Khan, E.M.; Bulabula, A.N.H.; et al. Burden of bacterial antimicrobial resistance in low-income and middle-income countries avertible by existing interventions: An evidence review and modelling analysis. Lancet 2024, 403, 2439–2454. [CrossRef]
- World Bank Group. Pulling Together to Beat Superbugs Knowledge and Implementation Gaps in Addressing Antimicrobial Resistance. 2019. Available at URL: https://openknowledge.worldbank.org/bitstream/handle/10986/32552/Pulling-Together-to-Beat-Superbugs-Knowledge-and-Implementation-Gaps-in-Addressing-Antimicrobial-Resistance.pdf?sequence=1&isAllowed=y.
- Hofer U. The cost of antimicrobial resistance. Nat. Rev. Microbiol. 2019, 17, 3. [CrossRef]
- Atif M, Zia R, Malik I, Ahmad N, Sarwar S. Treatment outcomes, antibiotic use and its resistance pattern among neonatal sepsis patients attending Bahawal Victoria Hospital, Pakistan. PLoS One. 2021;16(1):e0244866. [CrossRef]
- Okomo U, Akpalu ENK, Le Doare K, Roca A, Cousens S, Jarde A, et al. Aetiology of invasive bacterial infection and antimicrobial resistance in neonates in sub-Saharan Africa: a systematic review and meta-analysis in line with the STROBE-NI reporting guidelines. Lancet Infect Dis. 2019;19(11):1219-34. [CrossRef]
- Al Jarousha AM, El Jadba AH, Al Afifi AS, El Qouqa IA. Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine. Int J Infect Dis. 2009;13(5):623-8. [CrossRef]
- Le Doare K, Barker CI, Irwin A, Sharland M. Improving antibiotic prescribing for children in the resource-poor setting. Br J Clin Pharmacol. 2015;79(3):446-55. [CrossRef]
- Ibrahim BA, Damiri B, Allabadi H, Qadi M. Bacteriological profile and antibiotic susceptibility pattern of septicemia in neonatal intensive care units in Palestine: A retrospective study. IJID Reg. 2024;10:87-93. [CrossRef]
- Donkor ES, Muhsen K, Johnson SAM, Kotey FCN, Dayie N, Tetteh-Quarcoo PB, et al. Multicenter Surveillance of Antimicrobial Resistance among Gram-Negative Bacteria Isolated from Bloodstream Infections in Ghana. Antibiotics. 2023;12(2). [CrossRef]
- Karataş Y, Khan Z. Antibiotic usage in the Pediatric population: the need for effective role of parents and prescribers. Güncel Pediatri. 2021;19(1):135-40. [CrossRef]
- Miao R, Wan C, Wang Z, Zhu Y, Zhao Y, Zhang L, et al. Inappropriate antibiotic prescriptions among pediatric inpatients in different type hospitals. Medicine. 2020;99(2):e18714. [CrossRef]
- Romandini A, Pani A, Schenardi PA, Pattarino GAC, De Giacomo C, Scaglione F. Antibiotic resistance in pediatric infections: global emerging threats, predicting the near future. Antibiotics. 2021;10(4):393. [CrossRef]
- Baig MT, Sial AA, Huma A, Ahmed M, Shahid U, Syed N. Irrational antibiotic prescribing practice among children in critical care of tertiary hospitals. Pak J Pharm Sci. 2017;30(4(Suppl.)):1483-9.
- Allwell-Brown G, Hussain-Alkhateeb L, Kitutu FE, Strömdahl S, Mårtensson A, Johansson EW. Trends in reported antibiotic use among children under 5 years of age with fever, diarrhoea, or cough with fast or difficult breathing across low-income and middle-income countries in 2005-17: a systematic analysis of 132 national surveys from 73 countries. Lancet Glob Health. 2020;8(6):e799-e807. [CrossRef]
- WHO. GLOBAL ACTION PLAN ON ANTIMICROBIAL RESISTANCE. 2015. Available at URL: https://apps.who.int/iris/bitstream/handle/10665/193736/9789241509763_eng.pdf?sequence=1 (Accessed 5 March 2025).
- Charani E, Mendelson M, Pallett SJC, Ahmad R, Mpundu M, Mbamalu O, et al. An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations. Lancet Glob Health. 2023;11(3):e466-e74. [CrossRef]
- Iwu, C.D.; Patrick, S.M. An insight into the implementation of the global action plan on antimicrobial resistance in the WHO African region: A roadmap for action. International Journal of Antimicrobial Agents 2021, 58, 106411. [CrossRef]
- Willemsen A, Reid S, Assefa Y. A review of national action plans on antimicrobial resistance: strengths and weaknesses. Antimicrob Resist Infect Control. 2022;11(1):90. [CrossRef]
- Godman, B.; Egwuenu, A.;Wesangula, E.; Schellack, N.; Kalungia, A.C.; Tiroyakgosi, C.; Kgatlwane, J.; Mwita, J.C.; Patrick, O.; Niba, L.L.; et al. Tackling antimicrobial resistance across sub-Saharan Africa: Current challenges and implications for the future. Expert Opin. Drug Saf. 2022, 21, 1089–1111. [CrossRef]
- Ghana Ministry of Health, Ministry of Food and Agriculture, Ministry of Environment, Science, Technology and Innovation, Ministry of Fisheries and Aquaculture Development. Ghana National Action Plan for Antimicrobial Use and Resistance. 2017 - 2021. Available at URL: http://www.moh.gov.gh/wp-content/uploads/2018/04/NAP_FINAL_PDF_A4_19.03.2018-SIGNED-1.pdf (Accessed 4 March 2025).
- Jimah T OO. National Action Plan on Antimicrobial Resistance: stakeholder analysis of implementation in Ghana. Journal of Global Health Reports. 2020;4(e2020067.):1-16. doi:0.29392/001c.13695.
- Nathwani D, Varghese D, Stephens J, Ansari W, Martin S, Charbonneau C. Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrob Resist Infect Control. 2019;8:35. [CrossRef]
- Sneddon J, Drummond F, Guise T, Gilchrist M, Jenkins DR. Accreditation of antimicrobial stewardship programmes: addressing a global need to tackle antimicrobial resistance. JAC-Antimicrobial Resistance. 2024;6(1). [CrossRef]
- Ashiru-Oredope D, Garraghan F, Olaoye O, Krockow EM, Matuluko A, Nambatya W, et al. Development and Implementation of an Antimicrobial Stewardship Checklist in Sub-Saharan Africa: A Co-Creation Consensus Approach. Healthcare. 2022;10(9). [CrossRef]
- Sharland M, Pulcini C, Harbarth S, Zeng M, Gandra S, Mathur S, et al. Classifying antibiotics in the WHO Essential Medicines List for optimal use—be AWaRe. Lancet Infect Dis. 2018;18(1):18–20. [CrossRef]
- Sharland, M.; Gandra, S.; Huttner, B.; Moja, L.; Pulcini, C.; Zeng, M.; Mendelson, M.; Cappello, B.; Cooke, G.; Magrini, N., et al. Encouraging AWaRe-ness and discouraging inappropriate antibiotic use—the new 2019 Essential Medicines List becomes a global antibiotic stewardship tool. The Lancet Infectious Diseases 2019, 19, 1278-1280. [CrossRef]
- . WHO. The WHO AWaRe (Access, Watch, Reserve) antibiotic book. 2022 Available at URL: https://www.who.int/publications/i/item/9789240062382 (Accesses 6 April, 2025).
- Zanichelli, V.; Sharland, M.; Cappello, B.; Moja, L.; Getahun, H.; Pessoa-Silva, C.; Sati, H.; van Weezenbeek, C.; Balky, H.; Simao, M.; et al. The WHO AWaRe (Access, Watch, Reserve) antibiotic book and prevention of antimicrobial resistance. Bull. World Health Organ. 2023, 101, 290–296. [CrossRef]
- Moja, L.; Zanichelli, V.; Mertz, D.; Gandra, S.; Cappello, B.; Cooke, G.S.; Chuki, P.; Harbath, S.; Pulcini, C.; Mendelson, M.; et al. WHO’s essential medicines and AWaRe: Recommendations on first- and second-choice antibiotics for empiric treatment of clinical infections. Clin. Microbiol. Infect. 2024, 30, S1–S51. [CrossRef]
- Johnson S, Lavergne V, Skinner AM, Gonzales-Luna AJ, Garey KW, Kelly CP, et al. Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clin Infect Dis. 2021;73(5):e1029-e44. [CrossRef]
- Funiciello, E.; Lorenzetti, G.; Cook, A.; Goelen, J.; Moore, C.E.; Campbell, S.M.; Godman, B.; Tong, D.; Huttner, B.; Chuki, P.; et al. Identifying AWaRe indicators for appropriate antibiotic use: A narrative review. J. Antimicrob. Chemother. 2024, 79, 12. [CrossRef]
- Pauwels I, Versporten A, Drapier N, Vlieghe E, Goossens H. Hospital antibiotic prescribing patterns in adult patients according to the WHO Access, Watch and Reserve classification (AWaRe): results from a worldwide point prevalence survey in 69 countries. J Antimicrob Chemother. 2021;76(6):1614-24. [CrossRef]
- Saleem Z, Sheikh S, Godman B, Haseeb A, Afzal S, Qamar MU, et al. Increasing the use of the WHO AWaRe system in antibiotic surveillance and stewardship programmes in low- and middle-income countries. JAC-Antimicrobial Resistance. 2025;7(2). [CrossRef]
- United Nations. Political Declaration of the High-level Meeting on Antimicrobial Resistance. 9 September 2024 Available at URL: https://www.un.org/pga/wp-content/uploads/sites/108/2024/09/FINAL-Text-AMR-to-PGA.pdf (Accessed 5 March 2025).
- Klein EY, Milkowska-Shibata M, Tseng KK, Sharland M, Gandra S, Pulcini C, et al. Assessment of WHO antibiotic consumption and access targets in 76 countries, 2000-15: an analysis of pharmaceutical sales data. Lancet Infect Dis. 2021;21(1):107-15. [CrossRef]
- Sulis, G.; Sayood, S.; Katukoori, S.; Bollam, N.; George, I.; Yaeger, L.H.; Chavez, M.A.; Tetteh, E.; Yarrabelli, S.; Pulcini, C., et al. Exposure to World Health Organization's AWaRe antibiotics and isolation of multidrug resistant bacteria: a systematic review and meta-analysis. Clinical Microbiology and Infection 2022, 28, 1193-1202. [CrossRef]
- Abu-Ajaleh S, Darwish Elhajji F, Al-Bsoul S, Abu Farha R, Al-Hammouri F, Amer A, et al. An Evaluation of the Impact of Increasing the Awareness of the WHO Access, Watch, and Reserve (AWaRe) Antibiotics Classification on Knowledge, Attitudes, and Hospital Antibiotic Prescribing Practices. Antibiotics. 2023;12(6). [CrossRef]
- Amponsah OKO, Courtenay A, Ayisi-Boateng NK, Abuelhana A, Opoku DA, Blay LK, et al. Assessing the impact of antimicrobial stewardship implementation at a district hospital in Ghana using a health partnership model. JAC-Antimicrobial Resistance. 2023;5(4). [CrossRef]
- Sefah IA, Denoo EY, Bangalee V, Kurdi A, Sneddon J, Godman B. Appropriateness of surgical antimicrobial prophylaxis in a teaching hospital in Ghana: findings and implications. JAC Antimicrob Resist. 2022;4(5):dlac102. [CrossRef]
- Afriyie DK, Sefah IA, Sneddon J, Malcolm W, McKinney R, Cooper L, et al. Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship. JAC Antimicrob Resist. 2020;2(1):dlaa001. [CrossRef]
- Sefah IA, Essah DO, Kurdi A, Sneddon J, Alalbila TM, Kordorwu H, et al. Assessment of adherence to pneumonia guidelines and its determinants in an ambulatory care clinic in Ghana: findings and implications for the future. JAC Antimicrob Resist. 2021;3(2):dlab080. [CrossRef]
- Sefah IA, Nyamadi D, Kurdi A, Bugri AA, Kerr F, Yamoah P, et al. Assessment of the quality of antimicrobial prescribing among hospitalized patients in a teaching hospital in Ghana: findings and implications. Hosp Pract. 2023;51(4):223-32. [CrossRef]
- Agyare E, Acolatse JEE, Dakorah MP, Akafity G, Chalker VJ, Spiller OB, et al. Antimicrobial stewardship capacity and antibiotic utilisation practices in the Cape Coast Teaching Hospital, Ghana: A point prevalence survey study. PLoS One. 2024;19(1):e0297626. [CrossRef]
- Labi AK, Obeng-Nkrumah N, Sunkwa-Mills G, Bediako-Bowan A, Akufo C, Bjerrum S, et al. Antibiotic prescribing in paediatric inpatients in Ghana: a multi-centre point prevalence survey. BMC Pediatr. 2018;18(1):391. [CrossRef]
- Labi AK, Obeng-Nkrumah N, Nartey ET, Bjerrum S, Adu-Aryee NA, Ofori-Adjei YA, et al. Antibiotic use in a tertiary healthcare facility in Ghana: a point prevalence survey. Antimicrob Resist Infect Control. 2018;7:15. [CrossRef]
- Labi AK, Obeng-Nkrumah N, Dayie N, Egyir B, Sampane-Donkor E, Newman MJ, et al. Antimicrobial use in hospitalized patients: a multicentre point prevalence survey across seven hospitals in Ghana. JAC Antimicrob Resist. 2021;3(3):dlab087. [CrossRef]
- Bediako-Bowan AAA, Owusu E, Labi AK, Obeng-Nkrumah N, Sunkwa-Mills G, Bjerrum S, et al. Antibiotic use in surgical units of selected hospitals in Ghana: a multi-centre point prevalence survey. BMC Public Health. 2019;19(1):797. [CrossRef]
- Adadey SM, Ayee R, Languon S, Quansah D, Quaye O. Patterns of Frequently Diagnosed Pediatric Morbidities in Hospitalized Children in the Volta Region of Ghana. Glob Pediatr Health. 2019;6:2333794x19889230. [CrossRef]
- Sefah IA, Sarkodie SA, Pichierri G, Schellack N, Godman B. Assessing the Clinical Characteristics and Management of COVID-19 among Pediatric Patients in Ghana: Findings and Implications. Antibiotics. 2023;12(2):283. [CrossRef]
- Amponsah OKO, Buabeng KO, Owusu-Ofori A, Ayisi-Boateng NK, Hämeen-Anttila K, Enlund H. Point prevalence survey of antibiotic consumption across three hospitals in Ghana. JAC Antimicrob Resist. 2021;3(1):dlab008. [CrossRef]
- Dodoo CC, Orman E, Alalbila T, Mensah A, Jato J, Mfoafo KA, et al. Antimicrobial Prescription Pattern in Ho Teaching Hospital, Ghana: Seasonal Determination Using a Point Prevalence Survey. Antibiotics. 2021;10(2). [CrossRef]
- Domapielle MK, Dassah C, Dordaa F, Cheabu BSN, Sulemana M. Barriers to health care access and utilization among aged indigents under the Livelihood Empowerment Against Poverty Programme (LEAP): the perspective of users and service providers in north-western Ghana. Prim Health Care Res Dev. 2023;24:e48. [CrossRef]
- Morales F, Montserrat-de la Paz S, Leon MJ, Rivero-Pino F. Effects of Malnutrition on the Immune System and Infection and the Role of Nutritional Strategies Regarding Improvements in Children's Health Status: A Literature Review. Nutrients. 2023;16(1). [CrossRef]
- Sneddon J, Cooper L, Afriyie DK, Sefah IA, Cockburn A, Kerr F, et al. Supporting antimicrobial stewardship in Ghana: evaluation of the impact of training on knowledge and attitudes of healthcare professionals in two hospitals. JAC Antimicrob Resist. 2020;2(4):dlaa092. [CrossRef]
- Dakorah MP, Agyare E, Acolatse JEE, Akafity G, Stelling J, Chalker VJ, et al. Utilising cumulative antibiogram data to enhance antibiotic stewardship capacity in the Cape Coast Teaching Hospital, Ghana. Antimicrob Resist Infect Control. 2022;11(1):122. [CrossRef]
- Mustafa ZU, Khan AH, Salman M, Harun SN, Meyer JC, Godman B. Paediatricians' knowledge, perceptions, preparedness and involvement towards paediatric antimicrobial stewardship in Pakistan: findings and the implications. JAC Antimicrob Resist. 2024;6(6):dlae193. [CrossRef]
- Moore DP, Chetty T, Pillay A, Karsas M, Cloete J, Balakrishna Y, et al. Antibiotic and antifungal use in paediatric departments at three academic hospitals in South Africa. IJID Reg. 2024;10:151-8. [CrossRef]
- Xavier SP, da Silva AMC, Victor A. Antibiotic prescribing patterns in pediatric patients using the WHO access, watch, reserve (AWaRe) classification at a quaternary hospital in Nampula, Mozambique. Sci Rep. 2024;14(1):22719. [CrossRef]
- Xavier SP, Victor A, Cumaquela G, Vasco MD, Rodrigues OAS. Inappropriate use of antibiotics and its predictors in pediatric patients admitted at the Central Hospital of Nampula, Mozambique. Antimicrob Resist Infect Control. 2022;11(1):79. [CrossRef]
- Umeokonkwo CD, Madubueze UC, Onah CK, Okedo-Alex IN, Adeke AS, Versporten A, et al. Point prevalence survey of antimicrobial prescription in a tertiary hospital in South East Nigeria: A call for improved antibiotic stewardship. J Glob Antimicrob Resist. 2019;17:291-5. [CrossRef]
- Mambula G, Nanjebe D, Munene A, Guindo O, Salifou A, Mamaty AA, et al. Practices and challenges related to antibiotic use in paediatric treatment in hospitals and health centres in Niger and Uganda: a mixed methods study. Antimicrob Resist Infect Control. 2023;12(1):67. [CrossRef]
- Sarker R, Khan MSI, Tareq MA, Ghosh S, Chowdhury S. Antibiotic Use Among Children Under 5 Years of Age in a Tertiary Care Hospital, Bangladesh. SN Comprehensive Clinical Medicine. 2021;3(4):982-8. [CrossRef]
- Abdel-Qader DH, Ismael NS, Albassam A, El-Shara’ AA, Aljamal MS, Ismail R, et al. Antibiotics use and appropriateness in two Jordanian children hospitals: a point prevalence study. Journal of Pharmaceutical Health Services Research. 2021;12(2):166-72. [CrossRef]
- Mandal P, Asad M, Kayal A, Biswas M. Assessment of use of World Health Organization access, watch, reserve antibiotics and core prescribing indicators in pediatric outpatients in a tertiary care teaching hospital in Eastern India. Perspect Clin Res. 2023;14(2):61-7. [CrossRef]
- Skosana PP, Schellack N, Godman B, Kurdi A, Bennie M, Kruger D, et al. A national, multicentre, web-based point prevalence survey of antimicrobial use and quality indices among hospitalised paediatric patients across South Africa. J Glob Antimicrob Resist. 2022;29:542-50. [CrossRef]
- Sefah IA, Chetty S, Yamoah P, Godman B, Bangalee V. An Assessment of the Current Level of Implementation of the Core Elements of Antimicrobial Stewardship Programs in Public Hospitals in Ghana. Hosp Pharm. 2024;59(3):367-77. [CrossRef]
- Ashiru-Oredope D, Nabiryo M, Zengeni L, Kamere N, Makotose A, Olaoye O, et al. Tackling antimicrobial resistance: developing and implementing antimicrobial stewardship interventions in four African commonwealth countries through a health partnership model. J Public Health Afr. 2023;14(6):2335. [CrossRef]
- Cox JA, Vlieghe E, Mendelson M, Wertheim H, Ndegwa L, Villegas MV, et al. Antibiotic stewardship in low- and middle-income countries: the same but different? Clin Microbiol Infect. 2017;23(11):812-8. [CrossRef]
- Dramowski A, Prusakov P, Goff DA, Brink A, Govender NP, Annor AS, et al. Prospective antimicrobial stewardship interventions by multidisciplinary teams to reduce neonatal antibiotic use in South Africa: The Neonatal Antimicrobial Stewardship (NeoAMS) study. Int J Infect Dis. 2024;146:107158. [CrossRef]
- Siachalinga L, Mufwambi W, Lee IH. Impact of antimicrobial stewardship interventions to improve antibiotic prescribing for hospital inpatients in Africa: a systematic review and meta-analysis. J Hosp Infect. 2022;129:124-43. [CrossRef]
- Otieno PA, Campbell S, Maley S, Obinju Arunga T, Otieno Okumu M. A Systematic Review of Pharmacist-Led Antimicrobial Stewardship Programs in Sub-Saharan Africa. Int J Clin Pract. 2022;2022:3639943. [CrossRef]
- Akpan MR, Isemin NU, Udoh AE, Ashiru-Oredope D. Implementation of antimicrobial stewardship programmes in African countries: a systematic literature review. J Glob Antimicrob Resist. 2020;22:317-24. [CrossRef]
- Al-Tawfiq JA, Alawami AH. A multifaceted approach to decrease inappropriate antibiotic use in a pediatric outpatient clinic. Annals of Thoracic Medicine. 2017;12(1):51-4. [CrossRef]
- Dooling KL, Shapiro DJ, Van Beneden C, Hersh AL, Hicks LA. Overprescribing and inappropriate antibiotic selection for children with pharyngitis in the United States, 1997-2010. JAMA pediatrics. 2014;168(11):1073-4. [CrossRef]
- Marc C, Vrignaud B, Levieux K, Robine A, Guen CG-L, Launay E. Inappropriate prescription of antibiotics in pediatric practice: analysis of the prescriptions in primary care. Journal of Child Health Care. 2016;20(4):530-6. [CrossRef]
- Mustafa ZU, Salman M, Aslam N, Asif N, Hussain K, Shehzadi N, et al. Antibiotic use among hospitalized children with lower respiratory tract infections: a multicenter, retrospective study from Punjab, Pakistan. Expert Rev Anti Infect Ther. 2022;20(1):131-6. [CrossRef]
- Tran-Quang K, Nguyen-Thi-Dieu T, Tran-Do H, Pham-Hung V, Nguyen-Vu T, Tran-Xuan B, et al. Antibiotic resistance of Streptococcus pneumoniae in Vietnamese children with severe pneumonia: a cross-sectional study. Front Public Health. 2023;11:1110903. [CrossRef]
- La Vecchia A, Teklie BG, Mulu DA, Toitole KK, Montalbetti F, Agostoni C, et al. Adherence to WHO guidelines on severe pneumonia management in children and its impact on outcome: an observational study at Jinka General Hospital in Ethiopia. Front Public Health. 2023;11:1189684. [CrossRef]
- Mwita JC, Ogunleye OO, Olalekan A, Kalungia AC, Kurdi A, Saleem Z, et al. Key Issues Surrounding Appropriate Antibiotic Use for Prevention of Surgical Site Infections in Low- and Middle-Income Countries: A Narrative Review and the Implications. Int J Gen Med. 2021;14:515-30. [CrossRef]
- STG. Ghana Standard Treatment Guidelines (STG) - Seventh Edition. Ministry of Health, Ghana Nationa Drug Programme. 2017. Available at URL: https://www.moh.gov.gh/wp-content/uploads/2020/07/GHANA-STG-2017-1.pdf (Accessed 1 March 2025).
- Aiken AM, Rehman AM, de Kraker MEA, Madrid L, Kebede M, Labi AK, et al. Mortality associated with third-generation cephalosporin resistance in Enterobacterales bloodstream infections at eight sub-Saharan African hospitals (MBIRA): a prospective cohort study. Lancet Infect Dis. 2023. [CrossRef]
- Dramowski A, Aiken AM, Rehman AM, Snyman Y, Reuter S, Grundmann H, et al. Mortality associated with third-generation cephalosporin resistance in Enterobacteriaceae bloodstream infections at one South African hospital. J Glob Antimicrob Resist. 2022;29:176-84. [CrossRef]
- Gold JM, Hall M, Shah SS, Thomson J, Subramony A, Mahant S, et al. Long length of hospital stay in children with medical complexity. J Hosp Med. 2016;11(11):750-6. [CrossRef]
- Triantafyllou C, Chorianopoulou E, Kourkouni E, Zaoutis TE, Kourlaba G. Prevalence, incidence, length of stay and cost of healthcare-acquired pressure ulcers in pediatric populations: A systematic review and meta-analysis. Int J Nurs Stud. 2021;115:103843. [CrossRef]
- Wald-Dickler N, Holtom PD, Phillips MC, Centor RM, Lee RA, Baden R, et al. Oral Is the New IV. Challenging Decades of Blood and Bone Infection Dogma: A Systematic Review. Am J Med. 2022;135(3):369-79.e1. [CrossRef]
- Shrayteh ZM, Rahal MK, Malaeb DN. Practice of switch from intravenous to oral antibiotics. Springerplus. 2014;3:717. [CrossRef]
- Nguyen PT, Tran HT, Fitzgerald DA, Graham SM, Marais BJ. Antibiotic use in children hospitalised with pneumonia in Central Vietnam. Arch Dis Child. 2020;105(8):713-9. [CrossRef]
- Davey P, Marwick CA, Scott CL, Charani E, McNeil K, Brown E, et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. Cochrane Database Syst Rev. 2017;2(2):Cd003543. [CrossRef]
- Van Dijck C, Vlieghe E, Cox JA. Antibiotic stewardship interventions in hospitals in low-and middle-income countries: a systematic review. Bull World Health Organ. 2018;96(4):266-80. [CrossRef]
- Saleem Z, Moore CE, Kalungia AC, Schellack N, Ogunleye O, Chigome A, et al. Status and implications of the knowledge, attitudes and practices towards AWaRe antibiotic use, resistance and stewardship among low- and middle-income countries. JAC-Antimicrobial Resistance. 2025;7(2). [CrossRef]
- Kerr, F.; Sefah, I.A.; Essah, D.O.; Cockburn, A.; Afriyie, D.; Mahungu, J.; Mirfenderesky, M.; Ankrah, D.; Aggor, A.; Barrett, S.; et al. Practical Pharmacist-Led Interventions to Improve Antimicrobial Stewardship in Ghana, Tanzania, Uganda and Zambia. Pharmacy. 2021;9(3). [CrossRef]
- Sefah IA, Chetty S, Yamoah P, Bangalee V. The impact of antimicrobial stewardship interventions on appropriate use of surgical antimicrobial prophylaxis in low- and middle-income countries: a systematic review. Systematic Reviews. 2024;13(1):306. [CrossRef]
- Pinto Jimenez C, Pearson M, Hennessey M, Nkereuwem E, Crocker C, Egbujo U, et al. Awareness of antibiotic resistance: a tool for measurement among human and animal health care professionals in LMICs and UMICs. J Antimicrob Chemother. 2023;78(3):620-35. [CrossRef]
- GSS. Ghana 2021 Population and Housing Census. Ghana Statistical Services. Available at URL: https://ghdx.healthdata.org/record/ghana-population-and-housing-census-2021#:~:text=The%20Ghana%202021%20Population%20and%20Housing%20Census%20was,2021%20and%20recorded%20a%20total%20population%20of%2030%2C832%2C019. (Accessed 1 March 2025).
- Versporten A, Zarb P, Caniaux I, Gros MF, Drapier N, Miller M, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 2018;6(6):e619-e29. [CrossRef]
- Global PPS. Documents. Available at URL: https://www.global-pps.com/documents/ (Accesssed 5 February 2025).
- WHO. Anatomical Therapeutic Chemical (ATC) Classification. 2021. Available at URL: https://www.who.int/tools/atc-ddd-toolkit/atc-classification (Accessed 6 February 2025).
- Chizimu JY, Mudenda S, Yamba K, Lukwesa C, Chanda R, Nakazwe R, et al. Antibiotic use and adherence to the WHO AWaRe guidelines across 16 hospitals in Zambia: a point prevalence survey. JAC Antimicrob Resist. 2024;6(5):dlae170. [CrossRef]
- Foxlee ND, Townell N, Heney C, McIver L, Lau CL. Strategies Used for Implementing and Promoting Adherence to Antibiotic Guidelines in Low- and Lower-Middle-Income Countries: A Systematic Review. Trop Med Infect Dis. 2021;6(3).
| Variable | Total, n (%) | Compliance to the Guideline | p-value | |
|---|---|---|---|---|
| Age (years) Mean ± SD | 2.39 ± 2.99 | Yes, n (%) | No, n (%) | |
| Duration of Admission (days) - Mean ± SD | 9.14 ± 10.73 | |||
| Duration of Antibiotics (days) - Mean ± SD | 3.03 ± 2.43 | |||
| Age (years) (n=319) 0-2 3-5 6-8 9-11 |
219 (68.65) 53 (16.61) 26 (8.15) 21 (6.58) |
99 (45.21) 20 (37.74) 10 (38.46) 6 (28.57) |
120 (54.79) 33 (62.26) 16 (61.54) 15 (71.43) |
0.393 |
| Gender (n=319) Male Female |
174 (54.55) 145 (45.45) |
76 (43.68) 59 (40.69) |
98 (56.32) 86 (59.31) |
0.591 |
| Residence (n=318) Rural Urban Peri-Urban |
149 (46.86) 144 (45.28) 25 (7.86) |
62 (41.61) 61 (42.36) 12 (48.00) |
87 (58.39) 83 (57.64) 13 (52.00) |
0.836 |
| Duration of Admission (days) (n=319) 1-5 5-10 >10 |
153 (47.96) 87 (27.27) 79 (24.76) |
69 (45.10) 36 (41.38) 30 (37.97) |
84 (54.90) 51 (58.62) 49 (62.03) |
0.569 |
| Treatment Based on Biomarker (n=319) | 0.304 | |||
| Yes | 308 (96.55) | 132 (42.86) | 176 (57.14) | |
| No | 11 (3.45) | 3 (27.27) | 8 (72.72) | |
| If Yes, (n=308) | 0.262 | |||
| WBC | 128 (41.56) | 49 (38.28) | 79 (61.72) | |
| WBC + CRP | 81 (26.30) | 38 (46.91) | 43 (53.09) | |
| WBC + Urine R/E | 58 (18.83) | 25 (43.10) | 33 (56.90) | |
| WBC + CRP + Urine R/E | 20 (6.49) | 7 (35.00) | 13 (65.00) | |
| Other | 21 (6.82) | 13 (61.90) | 8 (38.10) | |
| Number of Antibiotics (n=319) | 0.546 | |||
| 1 | 120 (37.62) | 46 (38.33) | 74 (61.67) | |
| 2 | 181 (56.74) | 83 (45.86) | 98 (54.14) | |
| 3 | 15 (4.71) | 5 (33.33) | 10 (66.67) | |
| 4 | 3 (0.93) | 1 (33.33) | 2 (66.67) | |
| Antibiotic Type (n=319) | <0.001* | |||
| Ceftriaxone | 66 (20.69) | 24 (36.36) | 42 (63.64) | |
| Cefotaxime + flucloxacillin | 51 (15.99) | 0 (0.00) | 51 (100.00) | |
| Ampicillin + gentamicin | 48 (15.05) | 48 (100.00) | 0 (0.00) | |
| Amoxicillin + clavulanic Acid | 24 (7.52) | 10 (41.67) | 14 (58.33) | |
| Ceftriaxone + metronidazole | 21 (6.58) | 9 (42.86) | 12 (57.14) | |
| Other^ | 109 (34.17) | 44 (40.37) | 65 (59.63) | |
| WHO AWaRe Category (n=317) | <0.001* | |||
| Access | 86 (27.13) | 63 (73.26) | 23 (26.74) | |
| Watch | 95 (29.97) | 40 (42.10) | 55 (57.89) | |
| Access + Watch | 136 (42.90) | 32 (23.53) | 104 (76.47) | |
| Route of Administration (n=319) | 0.009* | |||
| Intravenous | 264 (82.76) | 108 (40.91) | 156 (59.09) | |
| Oral | 15 (4.70) | 6 (40.00) | 9 (60.00) | |
| Topical | 5 (1.57) | 0 (0) | 5 (100.00) | |
| Intravenous + Oral | 27 (8.46) | 19 (70.37) | 8 (29.63) | |
| Other | 8 (2.51) | 2 (25.00) | 6 (75.00) | |
| Diagnosis (n=319) | <0.001* | |||
| Neonatal Sepsis | 77 (24.14) | 33 (42.86) | 44 (57.14) | |
| Neonatal Jaundice due to sepsis | 18 (5.64) | 11 (61.11) | 7 (38.89) | |
| Pneumonia | 46 (14.42) | 39 (84.78) | 7 (15.22) | |
| Surgical Wound Prophylaxis | 46 (14.42) | 2 (4.35) | 44 (95.65) | |
| Tonsillitis | 17 (5.33) | 11 (64.71) | 6 (35.29) | |
| Other# | 115 (36.05) | 44 (38.26) | 71 (61.74) | |
| Variable | aOR | 95% CI | p-value | |
|---|---|---|---|---|
| Antibiotic Name | ||||
| Amoxicillin + Clavulanic Acid (R) | 1.00 | |||
| Ceftriaxone | 0.12 | 0.02-0.95 | 0.044* | |
| Cefotaxime + Flucloxacillin | 1.00 | |||
| Ampicillin + Gentamicin | 1.00 | |||
| Ceftriaxone + Metronidazole | 0.38 | 0.05-3.09 | 0.368 | |
| Other | 0.35 | 0.07-1.86 | 0.220 | |
| WHO AWaRe Category | ||||
| Access (R) | 1.00 | |||
| Watch | 1.28 | 0.27-5.97 | 0.757 | |
| Access + Watch | 4.86 | 0.12-1.95 | 0.309 | |
| Route of Administration | ||||
| Intravenous (R) | 1.00 | |||
| Oral | 0.54 | 0.14-2.03 | 0.361 | |
| Topical | 1.00 | |||
| Intravenous + Oral | 1.26 | 0.38-4.16 | 0.703 | |
| Other | 0.38 | 0.05-2.61 | 0.322 | |
| Diagnosis | ||||
| Neonatal Sepsis (R) | 1.00 | |||
| Neonatal Jaundice due to sepsis | 1.00 | |||
| Pneumonia | 15.38 | 3.30-71.62 | <0.001* | |
| Surgical Wound Prophylaxis | 0.07 | 0.01-0.42 | 0.004* | |
| Tonsillitis | 1.00 | |||
| Other | 1.80 | 0.50-6.53 | 0.371 | |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
